Abstract
BACKGROUND The development of artificial intelligence (AI)-based medical systems heavily relies on the collection and annotation of sufficient data containing disorders. However, the preparation of data with complete disorder types and adequate annotations presents a significant challenge, limiting the diagnostic capabilities of existing AI-based medical systems. This study introduces a novel AI-based system that accurately detects a broad spectrum of disorders without requiring any disorder-containing data.
METHODS We obtained a training dataset of 21,429 disorder-free head computed tomography (CT) scans and proposed a learning algorithm called Inverse Supervised Learning (ISL). This algorithm learns and understands disorder-free samples instead of disorder-contained ones, enabling the identification of all types of disorders. We also developed a diagnosis and visualization software for clinical usage based on the system’s ability to provide visually understandable clues.
RESULTS The system achieved Area Under the Curve (AUC) values of 0.883, 0.868, and 0.866 on retrospective (127 disorder types, 9,967 scans), prospective (117 disorder types, 3,054 scans), and cross-center (46 disorder types, 554 scans) datasets, respectively. These results demonstrate that the system can detect far more disorder types than previous AI-based systems. Furthermore, the ISL-based systems achieved AUC values of 0.893 and 0.895 on pulmonary CT and retinal optical coherence tomography (OCT), respectively, demonstrating that ISL can generalize well to non-head and non-CT images.
CONCLUSIONS Our novel AI-based system, utilizing ISL, can accurately and broadly detect disorders without requiring disorder-containing data. This system not only outperforms previous AI-based systems in terms of disorder detection but also provides visually understandable clues, enhancing its clinical utility. The successful application of ISL to non-head and non-CT images further demonstrates its potential for broad-spectrum medical applications. (Funded by National Key R&D Program of China, National Natural Science Foundation of China)
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional Review Board of Chinese PLA General Hospital gave ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Added comparison results with radiologits and analysis results for diseases of different severity and lesion sizes.
